Cart
sales@molnova.com
Ketohexokinase inhibitor 1
CAS No. 2102501-84-6
Ketohexokinase inhibitor 1( —— )
Catalog No. M23954 CAS No. 2102501-84-6
Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor.
Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 500 | In Stock |
|
| 10MG | 713 | In Stock |
|
| 25MG | 1062 | In Stock |
|
| 50MG | 1431 | In Stock |
|
| 100MG | 1935 | In Stock |
|
| 500MG | 3888 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKetohexokinase inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionKetohexokinase inhibitor 1 is a ketohexokinase inhibitor.
-
DescriptionKetohexokinase inhibitor 1 is a ketohexokinase inhibitor (IC50s: 8.4 nM and 66 nM for KHK-C and KHK-A, respectively).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorKHK-A|KHK-C
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2102501-84-6
-
Formula Weight356.34
-
Molecular FormulaC16H19F3N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (350.79 mM)
-
SMILESC[C@@H](CC1)N1c1nc(N(C2)C[C@@H]3[C@H]2C3CC(O)=O)cc(C(F)(F)F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS. US 20170183328 A1
molnova catalog
related products
-
Nur77 modulator 1
Nur77 modulator 1 is a good Nur77 binder (K D = 3.58 μM). Nur77 modulator 1 up-regulates Nur77 expression, mediates sub-cellular localization of Nur77, induces Nur77-dependent ER stress and autophagy, and results in cell apoptosis. Anti-hepatoma activity .
-
6-Chloropurine
6-Chloropurine is a building block in chemical synthesiswith?Antitumor activities.
-
111-Undecanedicarbox...
Undecanedicarboxylic acid is an unusual odd-numbered dicarboxylic acid that appears in the urines of children with neonatal adrenoleukodystrophy and Zellweger syndrome as an additional marker of these peroxisomal disorders.
